INCYTE CORPORATION Marketable Securities, Unrealized Gain (Loss)
INCYTE CORPORATION (INCY) reported Marketable Securities, Unrealized Gain (Loss) of -$159.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-22.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2012-02-22
- INCYTE CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2011-12-31 was $6.00K, a 89.29% decline year-over-year.
- INCYTE CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2011-09-30 was -$130.00K, a 141.01% decline year-over-year.
- INCYTE CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2011-06-30 was -$138.00K, a 123.08% decline year-over-year.
- INCYTE CORPORATION marketable securities, unrealized gain (loss) for the quarter ending 2011-03-31 was $103.00K, a 79.02% decline year-over-year.
- INCYTE CORPORATION marketable securities, unrealized gain (loss) for fiscal 2011 was -$159.00K, a 110.88% decline from fiscal 2010.
- INCYTE CORPORATION marketable securities, unrealized gain (loss) for fiscal 2010 was $1.46M, a 33.55% decline from fiscal 2009.
- INCYTE CORPORATION marketable securities, unrealized gain (loss) for fiscal 2009 was $2.20M.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2011-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$124.00K derived: sum of 2 quarters · filed 2012-02-22 | -$262.00K derived: sum of 3 quarters · filed 2012-02-22 | -$159.00K 10-K · filed 2012-02-22 |
| 2011-09-30 | -$130.00K 10-Q · filed 2011-10-27 | -$268.00K derived: sum of 2 quarters · filed 2011-10-27 | -$165.00K 10-Q · filed 2011-10-27 | -$109.00K derived: sum of 4 quarters · filed 2012-02-22 |
| 2011-06-30 | -$138.00K 10-Q · filed 2011-07-28 | -$35.00K 10-Q · filed 2011-07-28 | $21.00K derived: sum of 3 quarters · filed 2012-02-22 | $338.00K derived: sum of 4 quarters · filed 2012-02-22 |
| 2011-03-31 | $103.00K 10-Q · filed 2011-05-03 | $159.00K derived: sum of 2 quarters · filed 2012-02-22 | $476.00K derived: sum of 3 quarters · filed 2012-02-22 | $1.07M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $373.00K derived: sum of 2 quarters · filed 2012-02-22 | $971.00K derived: sum of 3 quarters · filed 2012-02-22 | $1.46M 10-K · filed 2012-02-22 |
| 2010-09-30 | $317.00K 10-Q · filed 2011-10-27 | $915.00K derived: sum of 2 quarters · filed 2011-10-27 | $1.41M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $598.00K 10-Q · filed 2011-07-28 | $1.09M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $491.00K 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $2.20M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |